Cell injury unmasks a latent proangiogenic phenotype in mice with increased expression of FGF2 in the retina

Haruhiko Yamada, Eri Yamada, Nohoon Kwak, Akira Ando, Akiko Suzuki, Noriko Esumi, Donald J Zack, Peter A Campochiaro

Research output: Contribution to journalArticle

Abstract

Fibroblast growth factor-2 (FGF2) is a potent mitogen for vascular endothelial cells and exogenous administration of FGF2 stimulates angiogenesis. However, increased expression of FGF2 in the retina does not cause angiogenesis. One possible explanation is that FGF2 may not be capable of initiating angiogenesis unless it is administered in pharmacologic levels or there is coexpression of another angiogenic factor. Alternatively, there may be control mechanisms that sequester FGF2 in vivo, preventing it from manifesting its in vitro angiogenic activity. We tested the first hypothesis by crossing mice that express FGF2 in the retina with mice that express vascular endothelial growth factor (VEGF) in the retina. Surprisingly, despite comparable levels of VEGF expression, mice that expressed both FGF2 and VEGF had significantly less neovascularization than mice that expressed VEGF alone. The second hypothesis was tested by treating Rho/FGF2 transgenic mice with low-intensity laser photocoagulation that disrupts photoreceptors, but does not rupture Bruch's membrane, or intense laser that ruptures Bruch's membrane. In Rho/FGF2 transgenics, but not wild type mice, choroidal neovascularization developed in areas of low-intensity laser. Both wild type and transgenic mice developed choroidal neovascularization in areas of intense laser that ruptured Bruch's membrane, but the area of neovascularization was significantly greater in transgenics. These data suggest that increased retinal expression of FGF2 is angiogenic only when it is accompanied by cell injury that overcomes sequestration control mechanisms. (C) 2000 Wiley-Liss, Inc.

Original languageEnglish (US)
Pages (from-to)135-142
Number of pages8
JournalJournal of Cellular Physiology
Volume185
Issue number1
DOIs
StatePublished - 2000

Fingerprint

Fibroblast Growth Factor 2
Retina
Phenotype
Wounds and Injuries
Bruch Membrane
Vascular Endothelial Growth Factor A
Lasers
Choroidal Neovascularization
Membranes
Transgenic Mice
Rupture
Light Coagulation
Angiogenesis Inducing Agents
Endothelial cells
Mitogens
Endothelial Cells

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology
  • Physiology

Cite this

Cell injury unmasks a latent proangiogenic phenotype in mice with increased expression of FGF2 in the retina. / Yamada, Haruhiko; Yamada, Eri; Kwak, Nohoon; Ando, Akira; Suzuki, Akiko; Esumi, Noriko; Zack, Donald J; Campochiaro, Peter A.

In: Journal of Cellular Physiology, Vol. 185, No. 1, 2000, p. 135-142.

Research output: Contribution to journalArticle

@article{4b93403325524630b5f3d7ce5cb01a46,
title = "Cell injury unmasks a latent proangiogenic phenotype in mice with increased expression of FGF2 in the retina",
abstract = "Fibroblast growth factor-2 (FGF2) is a potent mitogen for vascular endothelial cells and exogenous administration of FGF2 stimulates angiogenesis. However, increased expression of FGF2 in the retina does not cause angiogenesis. One possible explanation is that FGF2 may not be capable of initiating angiogenesis unless it is administered in pharmacologic levels or there is coexpression of another angiogenic factor. Alternatively, there may be control mechanisms that sequester FGF2 in vivo, preventing it from manifesting its in vitro angiogenic activity. We tested the first hypothesis by crossing mice that express FGF2 in the retina with mice that express vascular endothelial growth factor (VEGF) in the retina. Surprisingly, despite comparable levels of VEGF expression, mice that expressed both FGF2 and VEGF had significantly less neovascularization than mice that expressed VEGF alone. The second hypothesis was tested by treating Rho/FGF2 transgenic mice with low-intensity laser photocoagulation that disrupts photoreceptors, but does not rupture Bruch's membrane, or intense laser that ruptures Bruch's membrane. In Rho/FGF2 transgenics, but not wild type mice, choroidal neovascularization developed in areas of low-intensity laser. Both wild type and transgenic mice developed choroidal neovascularization in areas of intense laser that ruptured Bruch's membrane, but the area of neovascularization was significantly greater in transgenics. These data suggest that increased retinal expression of FGF2 is angiogenic only when it is accompanied by cell injury that overcomes sequestration control mechanisms. (C) 2000 Wiley-Liss, Inc.",
author = "Haruhiko Yamada and Eri Yamada and Nohoon Kwak and Akira Ando and Akiko Suzuki and Noriko Esumi and Zack, {Donald J} and Campochiaro, {Peter A}",
year = "2000",
doi = "10.1002/1097-4652(200010)185:1<135::AID-JCP13>3.0.CO;2-Y",
language = "English (US)",
volume = "185",
pages = "135--142",
journal = "Journal of Cellular Physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Cell injury unmasks a latent proangiogenic phenotype in mice with increased expression of FGF2 in the retina

AU - Yamada, Haruhiko

AU - Yamada, Eri

AU - Kwak, Nohoon

AU - Ando, Akira

AU - Suzuki, Akiko

AU - Esumi, Noriko

AU - Zack, Donald J

AU - Campochiaro, Peter A

PY - 2000

Y1 - 2000

N2 - Fibroblast growth factor-2 (FGF2) is a potent mitogen for vascular endothelial cells and exogenous administration of FGF2 stimulates angiogenesis. However, increased expression of FGF2 in the retina does not cause angiogenesis. One possible explanation is that FGF2 may not be capable of initiating angiogenesis unless it is administered in pharmacologic levels or there is coexpression of another angiogenic factor. Alternatively, there may be control mechanisms that sequester FGF2 in vivo, preventing it from manifesting its in vitro angiogenic activity. We tested the first hypothesis by crossing mice that express FGF2 in the retina with mice that express vascular endothelial growth factor (VEGF) in the retina. Surprisingly, despite comparable levels of VEGF expression, mice that expressed both FGF2 and VEGF had significantly less neovascularization than mice that expressed VEGF alone. The second hypothesis was tested by treating Rho/FGF2 transgenic mice with low-intensity laser photocoagulation that disrupts photoreceptors, but does not rupture Bruch's membrane, or intense laser that ruptures Bruch's membrane. In Rho/FGF2 transgenics, but not wild type mice, choroidal neovascularization developed in areas of low-intensity laser. Both wild type and transgenic mice developed choroidal neovascularization in areas of intense laser that ruptured Bruch's membrane, but the area of neovascularization was significantly greater in transgenics. These data suggest that increased retinal expression of FGF2 is angiogenic only when it is accompanied by cell injury that overcomes sequestration control mechanisms. (C) 2000 Wiley-Liss, Inc.

AB - Fibroblast growth factor-2 (FGF2) is a potent mitogen for vascular endothelial cells and exogenous administration of FGF2 stimulates angiogenesis. However, increased expression of FGF2 in the retina does not cause angiogenesis. One possible explanation is that FGF2 may not be capable of initiating angiogenesis unless it is administered in pharmacologic levels or there is coexpression of another angiogenic factor. Alternatively, there may be control mechanisms that sequester FGF2 in vivo, preventing it from manifesting its in vitro angiogenic activity. We tested the first hypothesis by crossing mice that express FGF2 in the retina with mice that express vascular endothelial growth factor (VEGF) in the retina. Surprisingly, despite comparable levels of VEGF expression, mice that expressed both FGF2 and VEGF had significantly less neovascularization than mice that expressed VEGF alone. The second hypothesis was tested by treating Rho/FGF2 transgenic mice with low-intensity laser photocoagulation that disrupts photoreceptors, but does not rupture Bruch's membrane, or intense laser that ruptures Bruch's membrane. In Rho/FGF2 transgenics, but not wild type mice, choroidal neovascularization developed in areas of low-intensity laser. Both wild type and transgenic mice developed choroidal neovascularization in areas of intense laser that ruptured Bruch's membrane, but the area of neovascularization was significantly greater in transgenics. These data suggest that increased retinal expression of FGF2 is angiogenic only when it is accompanied by cell injury that overcomes sequestration control mechanisms. (C) 2000 Wiley-Liss, Inc.

UR - http://www.scopus.com/inward/record.url?scp=0033838367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033838367&partnerID=8YFLogxK

U2 - 10.1002/1097-4652(200010)185:1<135::AID-JCP13>3.0.CO;2-Y

DO - 10.1002/1097-4652(200010)185:1<135::AID-JCP13>3.0.CO;2-Y

M3 - Article

C2 - 10942527

AN - SCOPUS:0033838367

VL - 185

SP - 135

EP - 142

JO - Journal of Cellular Physiology

JF - Journal of Cellular Physiology

SN - 0021-9541

IS - 1

ER -